Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, $0.0001 Par Value
-
Shares outstanding
-
6.47M
-
Number of holders
-
19
-
Total 13F shares, excl. options
-
281K
-
Shares change
-
+206K
-
Total reported value, excl. options
-
$427K
-
Value change
-
+$329K
-
Number of buys
-
11
-
Number of sells
-
-6
-
Price
-
$1.52
Significant Holders of MUSTANG BIO, INC. - Common Stock, $0.0001 Par Value (MBIO) as of Q3 2025
22 filings reported holding MBIO - MUSTANG BIO, INC. - Common Stock, $0.0001 Par Value as of Q3 2025.
MUSTANG BIO, INC. - Common Stock, $0.0001 Par Value (MBIO) has 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 281K shares
of 6.47M outstanding shares and own 4.34% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (84.7K shares), Kestra Advisory Services, LLC (66.1K shares), VANGUARD GROUP INC (57.9K shares), GEODE CAPITAL MANAGEMENT, LLC (26.4K shares), XTX Topco Ltd (18.8K shares), RENAISSANCE TECHNOLOGIES LLC (11.8K shares), CFO4Life Group, LLC (10.5K shares), SBI Securities Co., Ltd. (2.01K shares), Tower Research Capital LLC (TRC) (1.33K shares), and CITIGROUP INC (602 shares).
This table shows the top 19 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.